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transredial approach (2 patients) was used to implant elents through 6 or 8 
French guiding catheters in 22 vessels (7 LAD, 5 RCA, 5 circumflex, 3 left 
main, 1 obtuse marginal, 1 SVG); 10 vessels had bifurcations at the site, and 
11 had > 45 Q curvature. Prepmcedure minimum lumen diameter (MLD) was 
1,1 4- 0,3 ram, diameter elenosis was 82 4- 7%, and lesion length was 31 4-17 
mm (16 to 66 ram). All sterile were successfully deployed at the intended site; 
4 vessels received multiple GR II stents (maximum 3). The post-stent MLD 
was 3,2 4- 0.5 rnm, with a residual stanosis of 3 ± 3%. Pest-precedure therapy 
for 17 patients consisted Of ticlopidine for 1 month and aspidn indefinitely; 1 
patient with atdal tibdllation received systemic anticoagulalion. No subacute 
thrombOses, deaths, myocardial infarctions, or repeat inte~ventioes occurred 
within the first 3 monlhs of clini~l follow-up. Conclusion: The new features 
facilitate slant placement compared to the currently available system initial 
clinical results appear promising. 
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Coronary stsnti~lg provides a rapidly applied nonsurgical alternative to uor- 
rect asute di6sections following unsuccessful balloon ang!oplasty. Although a 
variety of stents have been shown to be useful in this situation, the influence 
that the atent design may have in long-term OutCO~ ,s remains uncertain. 
In the prose~Jl study, 34 consecutive pts receiving a Gi~turce-Roubin (GR) 
stant were matched to 34 pts receiving a Palmaz-Schalz (PS) stant. Pts ware 
elegible if they had undergone successful coronary sterr~'~g for acute dissec- 
tion following balloon angiuplaely and a 6-month control angingraphic study 
had been pedormed. Group matching was performed according to vessel 
size (reference diameter [REID] by quantitative computerized angiography 
[QCA]), location of target lesion and dissection type (ALIA classification). 
FelloW-up clinical data (% free of cardiac death, revasculaJ~.ation and my- 
ocardial infarction [Ev-free]) and QCA angiographic follow-up data (late loss 
and minimal luminal diameter [MLDfu l, and % of restenosis ~ > 5(P/~ 
[Re]) were compared (X + SD): 
GR PS p value 
RefD (turn) 2.9 • 0.4 2.0 4- 0.4 ns 
Dissection length imm) 10.1 ~: 8.2 19.7 ± 5.7 ns 
MID post-slant (ram) 2.4 4- 0.5 2.5:1:0.5 ns 
MID fol~w-up (ram) 1.3 + 0.9 1.8 :~ 0.7 <0.05 
MID late loss (ram) 1.1:1:0.8 0.7 :l: 0.6 < 0.05 
Re (%) 15 i44%) 5 (15°/=) <0.05 
Ev-free (%) 24 (70%) 28 (85%) <0.05 
Conclusions: PS stenting for the management of acute coronary dissec- 
tions after angioplasty provides a better clinical outcome than GR stenting. 
This benefit is mainly determined by a lower late loss resulting in larger 
luminal diameter at 6-month fdilow-up with PS stenting. 
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The purpose of the present study was to evaluate progress of restenosis 
after successful Cordis (CD) stent placement and to compare it with Palmaz- 
Schatz(PS) efant placement by matched lesion analysis, From Jan.'94 to 
Feb.'95, CD slant plaCement was attempted in 92 consecutive patients(pts) 
with 94 lesions(Is) and successful single stent placement was achieved in 65 
pts. with 68 Is, Prospective sedal angiographic follow-up(F/U) was scheduled 
for next day, 1 month, 3 and 6 months after procedure. F/U angiogrem was 
completed in 60 lots, with 61 Is. Matching process was based on stenosis 
loCation, reference diameter (<_ 0.3 mm) and minimal umen diameter (MLD 
< 0.1 mm). All 61 Is. were matched identically selected from 586 consecutive 
sedes of successful P/S stsnt plaeereent (Feb.'g0-June'94). 
CD PS 
Reference diameter (ram) 3.144-0.44 3.14-;-0.44 NS 
MLD pre (ram) 1.04 + 0.29 0.99 ± 0.28 NS 
MLD post (ram) 2.81 ± 0.29 2.89 ± 0.35 NS 
MLD FlU (ram) 1.944- 0.5B 1.99 ± 0.66 NS 
Relative gain 0.574-0.11 0.61:1:0.13 NS 
Relative [sss 0.28 4- 0.19 0.29:1:0.21 NS 
In conclusion, although ;here was more complicated and restenotic lesions 
in CD slant group, renan'owing process didn't differ between groups in this 
relatively a small number of cohort. 
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Renal Arter ies With Nonarticulated Palmaz Stents 
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Stephen Janldns, Chnstepher J. White, Stephen R. Ramee. Ochsner Clinic, 
New Orleans LA 
To investigate the mechanism of restenosis following renal artery stenting, 
computer-assieled quantitative angiogmphic measurements were made at 
the proximal, middle and distal segments of the slant in 57 renal arteries 
treated with nonadiculated Palmaz " stants in 41 patients (28 male, 13 
female, mean age 66 years; range 37 to 84 years). Identical measurements 
were repeated at 6 month angiographic foflow-up {mean 255 ± 240 days). 
Mean reference vessel diameter (RVD) at baseline, post stent and at 6 
months was 5.1 ~ 1.2, 5.1 -4- 1.2 and 4.9 ± 1.2 mm respectively (p = NS). 
Mean minimum luminal diameter (MLD) at basefirre, post slanting and at 6 
months was 1.2 4- 0.6, 4.9 :E 1.1 and 3.3 ± 1.2 mm respectively (p < 0.0001 
versus baseline). 
Prox. (ram) Middle (ram) Distal (ram) 
MLD post-stenting 4.7 :t: 0.9 4.9 4-1.0 4.7 :t: 0.9 
MID at 6 months 3.6 :~ 1.0 ~ 3.7 • 1.1 ° 3.7 ± 1.1" 
Lumen loss at 6 monks 1.2 ± 0.7 1.2 :t: 1.0 1.2 ± 0.8 
Stent diameter post-slanting 5.4 :~ 0.7 5.3 ~: 0.7 5.3- 0.7 
Slant diameter St 6 months 4.9 :E 0.71" 4.8 --. 0.61, 4.8 ± 0.7 t
Slant recoil at 6 months 0.5 d: 0.4 0.4 ~- 0.3 0.3 4- 0.4 
Slant recoil in .dex t 41% 33% 25% 
$5tent rats, index = (stem recoil at 6 months + lumen loss at 6 months), *p < 0.001 
verSus MID post-slanting, tp < 0.001 versus Stent diameter post-=lentJng 
Stent diameter at 6 month follow-up was smaller than immediately post- 
stsnting suggesting that restenosiS is due to a combination of elant recoil and 
tissue ingrowth in these patients. Condusfon: Late lumen loss following stent 
deployment in the renal artsdes is predominantly due to tissue ingrowth. 
There is, however, significant stent recoil at 6 months which also contributes 
to the late lumen loss. 
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We previously repoded serum level of tipoproteln(a) [Lp(a)] was a dsk fac- 
tor for restenosis. To evaluate that apolipopmtein E (apsE) isoform which 
predisposes to premature coronary artery disease also has any predictive 
value for restenosis, 103 patients (age; 63.3 4- 9.7) who underwent elective 
PTCA were available for analysis. The quantitative analysis of the stenotJc 
coronary segments was carded Out. RestenoSts was defined as the presence 
of > 50% Stenesis at follow-up. Lp(a) was measured before PTCA. APSE 
phenotypes were determined by isoelectdc focusing and classitied into three 
categories; E2 (E2/2, E2/3), E3 (E3/3), E4 (E4/4, E4/3). Results:The median 
level of serum Lp(a) was 25.7 mg/dl in patients with restenosis (N = 50) 
compared with 21.1 mg/dl in those without restenosis (N = 53) (p < 0.05). 
The restenosis rate was significantly higher in patients with Lp(a) levels > 
30 mg/dl (N : 32) ~ in those with Lp(a) levels > 30 mg/dl (N = 71) (66% 
vs, 39%, p < 0.02). SanJm lipide and incidence of restenosis in patients with 
three apo E were as follows. One subject of F.2/4 was excluded. 
E2(N =5) E3(N=81) E41N = 16) 
T. (:hal. (mg/dl) 184.6 208.7 217.3 ns 
Lp{a) (mg/dl) 22.8 24.2 17.8 ns 
RestenoSis 1 (20%) 39 (46%) 11 (e7%} ns 
Lp(s} < ,"~1 mg/dl (N = 70) iN=S) (N = 54) (No 11) 
Restenosis 1 (20%) 18 (33%) 9 (82%) p < 0.02 
I.p(a) _> 3U mg/dl (N = 32) IN = 0) (N = 27) i N = 5) 
Restenosis 19 ('/1%) 2 (40%) ns 
Multiple regression analysis adjusted for age, gender, and totelcholesfeml 
revealed that Lp(a) and apsE4 were related with restenosis. Lp(a) (10 moJdi) 
(1.52; 1.15-2.10, p < 0.01), apoE4 (1,84; 1.04-3.82, p < 0.05), (Odd ratio; 
95% confidence interval, p value). Conclusions: Elevated levels of serum 
P 
